Deutsche Bank Ag\ Seres Therapeutics, Inc. Transaction History

Deutsche Bank Ag\

$287 Billion
Q3 2025

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Jun 02, 2025	BUY	$0.75 - $1.56 $4,652 - $9,676	6,203 New	6,203 $4,000
Q4 2023 Feb 14, 2024	SELL	$0.93 - $2.15 $45,407 - $104,973	-48,825 Reduced 88.73%	6,203 $8,000
Q3 2023 Nov 09, 2023	BUY	$2.33 - $5.07 $15,324 - $33,345	6,577 Added 13.57%	55,028 $130,000
Q2 2023 Aug 14, 2023	SELL	$4.67 - $6.55 $59,598 - $83,591	-12,762 Reduced 20.85%	48,451 $232,000
Q1 2023 May 15, 2023	BUY	$4.95 - $6.09 $67,958 - $83,609	13,729 Added 28.91%	61,213 $347,000

Q4 2022 Feb 13, 2023	BUY	$5.09 - $9.05 $81,475 - $144,863	16,007 Added 50.85%	47,484 $265,000
Q3 2022 Nov 14, 2022	SELL	$3.5 - $7.2 $29,879 - $61,466	-8,537 Reduced 21.34%	31,477 $202,000
Q2 2022 Aug 11, 2022	SELL	$2.7 - $7.62 $43,591 - $123,024	-16,145 Reduced 28.75%	40,014 $137,000
Q1 2022 May 13, 2022	SELL	$6.3 - $8.84 $1.41 Million - $1.98 Million	-223,820 Reduced 79.94%	56,159 $399,000
Q4 2021 Feb 11, 2022	BUY	$6.02 - $11.43 $1.21 Million - $2.3 Million	201,437 Added 256.47%	279,979 $2.33 Million
Q3 2021 Nov 04, 2021	BUY	$5.46 - $22.6 $172,404 - $713,617	31,576 Added 67.23%	78,542 $547,000
Q2 2021 Aug 11, 2021	SELL	$18.46 - $24.36 $294,400 - $388,493	-15,948 Reduced 25.35%	46,966 $1.12 Million
Q1 2021 May 13, 2021	BUY	$17.66 - $28.92 $305,906 - $500,952	17,322 Added 37.99%	62,914 $1.3 Million
Q4 2020 Feb 16, 2021	BUY	$23.25 - $37.73 $386,856 - $627,789	16,639 Added 57.47%	45,592 $1.12 Million
Q3 2020 Nov 12, 2020	BUY	$3.74 - $28.74 $20,887 - $160,512	5,585 Added 23.9%	28,953 $820,000
Q2 2020 Aug 13, 2020	BUY	$3.04 - $6.2 $33,339 - $67,995	10,967 Added 88.44%	23,368 $111,000
Q1 2020 May 14, 2020	SELL	$2.64 - $3.82 $1,958 - $2,834	-742 Reduced 5.65%	12,401 $45,000
Q4 2019 Feb 14, 2020	BUY	$2.99 - $4.42 $8,733 - $12,910	2,921 Added 28.58%	13,143 $44,000
Q3 2019 Nov 14, 2019	SELL	$2.29 - $4.16 $10,932 - $19,859	-4,774 Reduced 31.84%	10,222 $40,000
Q2 2019 Aug 14, 2019	SELL	$2.28 - $7.35 $19,131 - $61,673	-8,391 Reduced 35.88%	14,996 $46,000
Q1 2019 May 15, 2019	BUY	$4.83 - $7.21 $2,999 - $4,477	621 Added 2.73%	23,387 $159,000
Q4 2018 Feb 14, 2019	SELL	$4.52 - $8.88 $132,973 - $261,240	-29,419 Reduced 56.37%	22,766 $102,000
Q3 2018 Dec 21, 2021	BUY	$7.33 - $9.23 $82,645 - $104,068	11,275 Added 27.56%	52,185 $396,000
Q3 2018 Nov 14, 2018	SELL	$7.33 - $9.23 $76,107 - $95,835	-10,383 Reduced 20.24%	40,910 $309,000
Q2 2018 Apr 21, 2020	BUY	$6.91 - $9.55 $88,945 - $122,927	12,872 Added 33.5%	51,293 $441,000
Q2 2018 Aug 14, 2018	SELL	$6.91 - $9.55 $948,369 - $1.31 Million	-137,246 Reduced 78.13%	38,421 $330,000
Q1 2018 Oct 18, 2019	BUY	$7.34 - $11.16 $94,465 - $143,629	12,870 Added 7.91%	175,667 $1.29 Million
Q1 2018 May 15, 2018	SELL	$7.34 - $11.16 $472,644 - $718,625	-64,393 Reduced 28.34%	162,797 $1.19 Million
Q4 2017 Feb 14, 2018	BUY	$9.15 - $12.64 $1.23 Million - $1.7 Million	134,874 Added 146.1%	227,190 $2.3 Million
Q3 2017 Nov 14, 2017	BUY	$12.81 - $16.85 $1.18 Million - $1.56 Million	92,316	92,316 $1.48 Million

Others Institutions Holding MCRB

# of Institutions

Shares Held

1.78M

Call Options Held

Put Options Held

View Full List

About Seres Therapeutics, Inc.

Ticker MCRB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 124,072,000
Market Cap $2.21B
Description
Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate that has completed Phase III clinical trial for the ...

More about MCRB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.

Account